<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported)
November 2, 1995
SUNRISE MEDICAL INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation or organization)
0-12744 95-3836867
(Commission File Number) (I.R.S. Employer Identification No.)
2382 Faraday Avenue, Suite 200
Carlsbad, California 92008
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code
(619) 930-1500
<PAGE>
Item 5. Other Events.
On November 2, 1995, the Registrant issued the press release attached
hereto as Exhibit A announcing that it was aware of seven lawsuits (including a
derivative action) pertaining to its announcement on October 26, 1995 that it
had commenced an internal investigation of its financial controls and financial
statements for previously reported periods to determine the nature and extent of
accounting practices at a Company subsidiary that may have been inconsistent
with generally accepted accounting principles. In addition, the Company
announced that the lawsuits allege, among other things, violation of the federal
securities laws, constructive fraud and breach of fiduciary duty and that it
expected that additional similar lawsuits may be filed against it.
Item 7. Exhibits.
A. Press Release dated November 2, 1995
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SUNRISE MEDICAL INC.
By Steven Jaye
Vice President, General Counsel and
Secretary
Date: November 2, 1995
<PAGE>
[LETTERHEAD OF SUNRISE MEDICAL]
FOR IMMEDIATE RELEASE
November 2, 1995
CONTACTS: Marcia P. Vaughan, director of corporate communications
Sunrise Medical Inc.
(619) 930-1500
SUNRISE MEDICAL ACKNOWLEDGES LAWSUITS
-------------------------------------
CARLSBAD, Calif.--Sunrise Medical Inc. (NYSE:SMD) announced today that it
is aware of seven lawsuits (including a derivative action) pertaining to its
announcement last week that it had commenced an internal investigation of its
financial controls and financial statements for previously reported periods to
determine the nature and extent of accounting practices at a Sunrise subsidiary
that may have been inconsistent with generally accepted accounting principles.
The lawsuits allege, among other things, violation of the federal
securities laws, constructive fraud and breach of fiduciary duty. Sunrise
expects that additional similar lawsuits may be filed against it.
Sunrise Medical designs, manufactures and markets medical products used in
institutional and home care settings that address the recovery, rehabilitation
and respiratory needs of the patient.
# # #
